Valuation: China Isotope & Radiation Corporation

Market Cap 4.73B 5.51B 702M 608M 569M 519M 977M 66.92B 994M 6.67B 2.62B 33.5B 2.63B 2.58B 112B P/E 2024
8.03x
P/E 2025 17.7x
Enterprise Value 4.85B 5.64B 719M 623M 584M 532M 1B 68.6B 1.02B 6.84B 2.68B 34.34B 2.7B 2.64B 115B EV / Sales 2024
0.42x
EV / Sales 2025 0.82x
Free-Float
91.21%
Yield 2024
3.74%
Yield 2025 1.69%
Jul. 05 China Isotope to Form JV With Associate MT
Jul. 03 China Isotope & Radiation Corporation and CNNC Yuanke Enter into Shareholders? Agreement to Establish Joint Venture Company CNNC Fuyuan CI
Jun. 18 China Isotope & Radiation Corporation Approves Final Dividend for the Year Ended 31 December 2025, Payable on Before 17 August 2026 CI
Jun. 18 China Isotope & Radiation Corporation Appoints Zhang Guoliang as A Member of Legal Affairs Committee of the Board and A Member of Science and Technology Innovation Committee of the Board CI
May. 26 China Isotope Proposes Auditor Change MT
May. 26 China Isotope & Radiation Corporation Announces Ma Xiaoyu Resignation of Ma Xiaoyu as an Executive Director Member of the Legal Affairs Committee Science and Technology Innovation Committee, Effective May 26, 2026 CI
Mar. 27 China Isotope & Radiation final cash dividend of RMB0.2264 per share RE
Mar. 27 China Isotope & Radiation Corporation Proposes Final Dividend for the Year Ended December 31, 2025, Payable Before 17 August 2026 CI
Mar. 27 China Isotope & Radiation Corporation Reports Earnings Results for the Full Year Ended December 31, 2025 CI
Mar. 19 China Isotope & Radiation to buy 51% stake in Hunan Huifeng Engineering Detection RE
Mar. 13 China Isotope & Radiation Corporation, Zhonghe Headway and the People?s Government of Maoming Municipality Enter Strategic Cooperation Agreement CI
Mar. 13 China Isotope & Radiation says co and Zhonghe Headway enter strategic cooperation agreement with Maoming municipality RE
Mar. 02 China Isotope & Radiation's Unit Gets China Nod for Market Launch of Breath Analyzer MT
1 day+1.71%
1 week+1.06%
Current month+5.91%
1 month+0.94%
3 months-9.52%
6 months-21.56%
Current year-14.80%
1 week 16.7
Extreme 16.7
17.82
1 month 16.09
Extreme 16.09
17.99
Current year 16.09
Extreme 16.09
24.28
1 year 15.2
Extreme 15.2
25
3 years 9.03
Extreme 9.03
25
5 years 9.03
Extreme 9.03
29.85
10 years 9.03
Extreme 9.03
35.4
Manager TitleAgeSince
Chief Executive Officer 55 2024-08-01
Corporate Secretary - 2024-08-29
Corporate Secretary - 2024-08-29
Director TitleAgeSince
Director/Board Member 57 2017-02-21
Director/Board Member 54 2019-06-27
Director/Board Member 54 2019-12-29
Change 5-day change 1-year change 3-year change Capi.($)
+1.71%+1.06%-3.91%+26.36% 690M
-0.36%+4.82%+205.64%+370.61% 22.44B
+0.68%+1.65%-40.77%-21.44% 9.97B
+1.39%+23.82%+381.40%+17.16% 7.63B
-1.30%+44.47%-23.01% - 6.61B
-0.06%-0.19%+79.99%+46.26% 6.59B
-1.45%+0.75%-12.28%-13.75% 5.71B
-2.05%+9.51%+78.56%+100.57% 4.49B
+0.39%+2.79%-7.15%-16.31% 4.36B
-0.70%-4.54%-20.34%-35.79% 2.78B
Average -0.20%+50.44%+63.81%+52.63% 7.13B
Weighted average by Cap. -0.26%+83.28%+107.84%+135.46%

Financials

2024 2025
Net sales 7.57B 8.81B 1.12B 973M 911M 831M 1.56B 107B 1.59B 10.68B 4.18B 53.6B 4.22B 4.12B 179B 7.19B 8.36B 1.07B 923M 864M 789M 1.48B 102B 1.51B 10.13B 3.97B 50.86B 4B 3.91B 170B
Net income 407M 473M 60.27M 52.23M 48.9M 44.61M 83.95M 5.75B 85.37M 573M 225M 2.88B 226M 221M 9.6B 327M 381M 48.53M 42.05M 39.37M 35.92M 67.6M 4.63B 68.74M 462M 181M 2.32B 182M 178M 7.73B
Net Debt -109M -127M -16.15M -13.99M -13.1M -11.95M -22.49M -1.54B -22.87M -154M -60.17M -771M -60.62M -59.3M -2.57B 119M 138M 17.61M 15.26M 14.29M 13.04M 24.54M 1.68B 24.95M 168M 65.65M 841M 66.13M 64.69M 2.81B
Logo China Isotope & Radiation Corporation
China Isotope & Radiation Corp is a China-based company mainly engaged in the research, development, manufacturing and sale of diagnostic and therapeutic radiopharmaceuticals and radioactive source products. The Company operates five business segments. Pharmaceuticals segment is engaged in providing imaging diagnostic and therapeutic radiopharmaceuticals, urea breath test (UBT) kits and analyzers and in vitro diagnostic reagents and kits. Radioactive Source Products segment is engaged in providing various medical and industrial radioactive sources products as well as provision of related technical services. Irradiation segment is engaged in providing sterilization services. Radiation Therapy Equipment and Related Services segment is engaged in manufacturing Radiation therapy equipment. Other Businesses segment is engaged in providing trade services in relation to imported radioactive source, medical nuclides, imported radiopharmaceuticals, and other products.
Employees
3,578
Date Price Change Volume
26-08-11 HK$17.21 +1.71% 32,400
26-08-10 HK$16.92 +0.53% 75,200
26-08-07 HK$16.83 -0.53% 7,600
26-08-06 HK$16.92 -1.40% 16,400
26-08-05 HK$17.16 -1.27% 234,800

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 1763 Stock